BIOF BLUE BIOFUELS, INC.
Industrial Organic Chemicals · OTC · SEC CIK 1549145 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-21.1%
TTM EPS YoY-18.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-288.0%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets436.2%
Debt / equity—
Current ratio0.01x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.35x
Accruals ratio-187.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | $826,453 | $431,198 | $384,913 | $997,487 | $485,677 | $471,470 | $350,707 | $1.02M |
| SG&A expense | $555,192 | $397,408 | $274,585 | $289,984 | $350,577 | $431,134 | $338,098 | $944,388 |
| Operating income | -$1.38M | -$731,106 | -$659,498 | -$1.29M | -$836,254 | -$902,604 | -$688,805 | -$1.96M |
| Interest expense | $3,623 | $19,689 | $4,303 | — | $6,323 | $18,148 | — | — |
| Net income | -$1.39M | -$750,795 | -$663,801 | -$1.29M | -$422,547 | -$920,752 | -$243,833 | -$1.79M |
| EBITDA | -$1.36M | -$702,132 | -$628,121 | -$1.27M | -$805,915 | -$872,406 | -$658,879 | -$1.93M |
| EPS (basic) | -0.00 | -0.00 | -0.00 | — | -0.00 | -0.00 | -0.00 | — |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | — | -0.00 | -0.00 | -0.00 | — |
| Weighted avg. shares (diluted) | 324.06M | 321.22M | 319.23M | — | 312.17M | 310.05M | 308.46M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $6,473 | $22,040 | $8,665 | $65,200 | $95,194 | $8,026 | $7,583 | $48,797 |
| Current assets | $18,524 | $34,091 | $20,216 | $76,751 | $106,645 | $19,478 | $40,072 | $81,286 |
| PP&E, net | $574,519 | $529,719 | $524,810 | $555,109 | $585,408 | $615,746 | $641,988 | $539,648 |
| Intangibles | $57,863 | $58,942 | $60,020 | $61,098 | — | — | — | — |
| Total assets | $1.35M | $1.32M | $1.31M | $1.41M | $1.49M | $1.45M | $1.48M | $1.39M |
| Current liabilities | $3.68M | $3.38M | $3.12M | $2.98M | $2.39M | $2.45M | $2.33M | $2.21M |
| Total liabilities | $5.90M | $5.38M | $5.25M | $5.11M | $4.54M | $4.62M | $4.43M | $4.24M |
| Shareholders' equity | -$4.55M | -$4.06M | -$3.94M | -$3.71M | -$3.06M | -$3.17M | -$2.95M | -$2.85M |
| Shares outstanding | 324.42M | 323.52M | 320.95M | 317.87M | 314.72M | 311.88M | 308.63M | 307.96M |
| Cash flow statement | ||||||||
| Operating cash flow | -$341,859 | -$268,824 | -$418,535 | -$392,310 | -$153,969 | -$312,139 | $13,416 | -$212,008 |
| Capital expenditure | $71,208 | — | — | -$1 | -$67,252 | $31,521 | $104,630 | — |
| Free cash flow | -$413,067 | — | — | -$392,309 | -$86,717 | -$343,660 | -$91,214 | — |
| Investing cash flow | -$95,208 | -$47,801 | -$10,000 | -$10,184 | $66,137 | -$38,668 | -$154,630 | -$85,561 |
| Financing cash flow | $421,500 | $330,000 | $372,000 | $372,500 | $175,000 | $351,250 | $100,000 | $197,000 |
| Depreciation & amortization | $26,407 | $28,974 | $31,377 | $18,412 | $30,339 | $30,198 | $29,926 | $29,663 |
| Stock-based compensation | $890,834 | $388,530 | $76,855 | $202,354 | $258,562 | $351,322 | $88,165 | $1.21M |
Free plan shows the latest 8 periods; Pro shows all 52 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.